Our approach also relies on controlled delivery of hepatocyte regenerative stimuli, HGF and EGF, to the liver using mRNA-LNP23,24, which has been validated as clinically safe with the recent mRNA-based COVID-19 vaccines. This evidence concerns the gene HGF and COVID-19.